Yoon H, Shin Y, Ryoo BY, Jeong H, et al. Clinical outcomes of second-line therapy following disease progression on first-line modified FOLFIRINOX for borderline resectable and locally advanced pancreatic adenocarcinoma. Pancreatology 2024 Feb 19:S1424-3903(24)00031-0. doi: 10.1016/j.pan.2024.
PMID: 38395676